177 related articles for article (PubMed ID: 22735238)
1. A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization.
Scaramuzza S; Tonon G; Olianas A; Messana I; Schrepfer R; Orsini G; Caliceti P
J Control Release; 2012 Dec; 164(3):355-63. PubMed ID: 22735238
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the site-specific monoPEGylated rhG-CSF analogue pegteograstim.
Hong J; Lee B; Kang K; Lee SH; Ryu J; Jung G; Oh J; Jo EC; Kim CW
Biologicals; 2018 Jan; 51():54-61. PubMed ID: 29107446
[TBL] [Abstract][Full Text] [Related]
3. Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor.
Mero A; Fang Z; Pasut G; Veronese FM; Viegas TX
J Control Release; 2012 May; 159(3):353-61. PubMed ID: 22405905
[TBL] [Abstract][Full Text] [Related]
4. A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone.
Mero A; Schiavon M; Veronese FM; Pasut G
J Control Release; 2011 Aug; 154(1):27-34. PubMed ID: 21565230
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical and biologic comparability of a biosimilar granulocyte colony-stimulating factor with its reference product.
Sörgel F; Lerch H; Lauber T
BioDrugs; 2010 Dec; 24(6):347-57. PubMed ID: 20873878
[TBL] [Abstract][Full Text] [Related]
6. [Recombinant granulocyte-colony stimulating factor (filgrastim): optimization of conjugation with polyethylene glycol].
Puchkov IA; Kononova NV; Bobruskin AI; Bairamashvili DI; Mart'ianov VA; Shuster AM
Bioorg Khim; 2012; 38(5):545-54. PubMed ID: 23342488
[TBL] [Abstract][Full Text] [Related]
7. Tailored PEG for rh-G-CSF analogue site-specific conjugation.
Salmaso S; Bersani S; Scomparin A; Mastrotto F; Scherpfer R; Tonon G; Caliceti P
Bioconjug Chem; 2009 Jun; 20(6):1179-85. PubMed ID: 19469471
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the physicochemical properties of a biosimilar filgrastim with those of reference filgrastim.
Skrlin A; Radic I; Vuletic M; Schwinke D; Runac D; Kusalic T; Paskvan I; Krsic M; Bratos M; Marinc S
Biologicals; 2010 Sep; 38(5):557-66. PubMed ID: 20637652
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor.
Lee DL; Sharif I; Kodihalli S; Stewart DI; Tsvetnitsky V
J Interferon Cytokine Res; 2008 Feb; 28(2):101-12. PubMed ID: 18279105
[TBL] [Abstract][Full Text] [Related]
10. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group.
Son JP; Jun SW; Choi YK; Park HS; Son MK; Lee MY; Kang SH; Kang JS; Park YI
Anal Biochem; 2012 Apr; 423(2):286-93. PubMed ID: 22244804
[TBL] [Abstract][Full Text] [Related]
11. Complete sequencing of the recombinant granulocyte-colony stimulating factor (filgrastim) and detection of biotinylation by mass spectrometry.
Ahmed KE; Chen WQ; John JP; Kang SU; Lubec G
Amino Acids; 2010 Apr; 38(4):1043-9. PubMed ID: 19526310
[TBL] [Abstract][Full Text] [Related]
12. Optimization of PEGylation reaction time and molar ratio of rhG-CSF toward increasing bioactive potency of monoPEGylated protein.
Behi J; Hassiki R; Said NB; Bouhaouala-Zahar B; Benkhoud ML
Int J Biol Macromol; 2018 Apr; 109():888-895. PubMed ID: 29154875
[TBL] [Abstract][Full Text] [Related]
13. Cysteine-specific PEGylation of rhG-CSF via selenylsulfide bond.
Kunstelj M; Fidler K; Skrajnar S; Kenig M; Smilović V; Kusterle M; Caserman S; Zore I; Porekar VG; Jevševar S
Bioconjug Chem; 2013 Jun; 24(6):889-96. PubMed ID: 23600957
[TBL] [Abstract][Full Text] [Related]
14. Self-assembling nanocomposites for protein delivery: supramolecular interactions between PEG-cholane and rh-G-CSF.
Salmaso S; Bersani S; Mastrotto F; Tonon G; Schrepfer R; Genovese S; Caliceti P
J Control Release; 2012 Aug; 162(1):176-84. PubMed ID: 22727711
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and molecular modeling of PEGylated human growth hormone with agonist activity.
Khameneh B; Jaafari MR; Hassanzadeh-Khayyat M; Varasteh A; Chamani J; Iranshahi M; Mohammadpanah H; Abnous K; Saberi MR
Int J Biol Macromol; 2015 Sep; 80():400-9. PubMed ID: 26116386
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG.
Mero A; Spolaore B; Veronese FM; Fontana A
Bioconjug Chem; 2009 Feb; 20(2):384-9. PubMed ID: 19186937
[TBL] [Abstract][Full Text] [Related]
17. Analytical techniques and bioactivity assays to compare the structure and function of filgrastim (granulocyte-colony stimulating factor) therapeutics from different manufacturers.
Levy MJ; Gucinski AC; Sommers CD; Ghasriani H; Wang B; Keire DA; Boyne MT
Anal Bioanal Chem; 2014 Oct; 406(26):6559-67. PubMed ID: 24264620
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a site-specific PEGylated analog of exendin-4 and determination of the PEGylation site.
Qian X; Dong H; Tian H; Tong Y; Guo L; Hu X; Gao X; Yao W
Int J Pharm; 2013 Sep; 454(1):553-8. PubMed ID: 23827193
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a Long-Acting Site-Specific PEGylated Murine GM-CSF Analog and Analysis of Its Hematopoietic Properties in Normal and Cyclophosphamide-Treated Neutropenic Rats.
Cox GN; Lee JI; Rosendahl MS; Chlipala EA; Doherty DH
Protein J; 2020 Apr; 39(2):160-173. PubMed ID: 32172395
[TBL] [Abstract][Full Text] [Related]
20. Site-Specific Transglutaminase-Mediated Conjugation of Interferon α-2b at Glutamine or Lysine Residues.
Spolaore B; Raboni S; Satwekar AA; Grigoletto A; Mero A; Montagner IM; Rosato A; Pasut G; Fontana A
Bioconjug Chem; 2016 Nov; 27(11):2695-2706. PubMed ID: 27731976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
